SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-080001
Filing Date
2022-03-21
Accepted
2022-03-21 06:32:39
Documents
14
Period of Report
2022-03-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d325521d8k.htm   iXBRL 8-K 30083
2 EX-99.1 d325521dex991.htm EX-99.1 126081
3 EX-99.2 d325521dex992.htm EX-99.2 3526
  Complete submission text file 0001193125-22-080001.txt   326227

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA adgi-20220318.xsd EX-101.SCH 2848
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE adgi-20220318_lab.xml EX-101.LAB 18738
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adgi-20220318_pre.xml EX-101.PRE 11702
8 EXTRACTED XBRL INSTANCE DOCUMENT d325521d8k_htm.xml XML 3459
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Adagio Therapeutics, Inc. (Filer) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40703 | Film No.: 22754171
SIC: 2836 Biological Products, (No Diagnostic Substances)